Clinical Trial

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a first-in-human, multicenter, open-label, phase I/Ⅱa clinical study of HMPL-A580 in participants with unresectable, advanced or metastatic solid tumors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-01.
Status change: Not Yet Recruiting → Recruiting 2026-03-24
Trial Details
NCT Number NCT07396584
Lead Sponsor Hutchmed
Conditions Solid Tumors, Adult
Enrollment 186 participants
Start Date 2026-03-04
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-27